171 related articles for article (PubMed ID: 25722311)
1. [Not Available].
Mani LY; Huynh-Do U; Horn MP
Ther Umsch; 2015 Mar; 72(3):179-88. PubMed ID: 25722311
[TBL] [Abstract][Full Text] [Related]
2. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
Stahl RA; Hoxha E; Helmchen U
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
[TBL] [Abstract][Full Text] [Related]
3. [Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B; Lambeau G; Esnault V
Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
6. Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy.
Debiec H; Ronco P
Nat Rev Nephrol; 2011 Aug; 7(9):496-8. PubMed ID: 21826078
[No Abstract] [Full Text] [Related]
7. Membranous nephropathy.
Dantas M; Silva LBB; Pontes BTM; Dos Reis MA; de Lima PSN; Moysés Neto M
J Bras Nefrol; 2023; 45(2):229-243. PubMed ID: 37527529
[TBL] [Abstract][Full Text] [Related]
8. Recent advances and prognosis in idiopathic membranous nephropathy.
Segal PE; Choi MJ
Adv Chronic Kidney Dis; 2012 Mar; 19(2):114-9. PubMed ID: 22449349
[TBL] [Abstract][Full Text] [Related]
9. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
10. Primary membranous nephropathy in adolescence: A prospective study.
Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
[TBL] [Abstract][Full Text] [Related]
11. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment.
Lai WL; Yeh TH; Chen PM; Chan CK; Chiang WC; Chen YM; Wu KD; Tsai TJ
J Formos Med Assoc; 2015 Feb; 114(2):102-11. PubMed ID: 25558821
[TBL] [Abstract][Full Text] [Related]
12. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
Dahan K
Rev Med Interne; 2016 Oct; 37(10):674-679. PubMed ID: 27236434
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
[TBL] [Abstract][Full Text] [Related]
14. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
15. Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.
Murtas C; Ghiggeri GM
J Nephrol; 2016 Aug; 29(4):469-78. PubMed ID: 26810113
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
[TBL] [Abstract][Full Text] [Related]
18. [Membranous nephropathy: New insights in therapeutic approach].
Dahan K
Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
[TBL] [Abstract][Full Text] [Related]
19. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G; Lorenzen JM; Ma H; de Haan N; Seeger H; Zaghrini C; Brandt S; Kölling M; Wegmann U; Kiss B; Pál G; Gál P; Wüthrich RP; Wuhrer M; Beck LH; Salant DJ; Lambeau G; Kistler AD
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33351779
[TBL] [Abstract][Full Text] [Related]
20. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
